Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sweeney

Showing results (721-730 of 762) with videos related to

Pageof 77
Sort By:
The New Phytologist|July 1, 2021
An integrated framework of plant form and function: the belowground perspectiveAlexandra Weigelt, Liesje Mommer, Karl Andraczek, et al.
The Prostate|May 6, 2021
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancerVictoria Wang, Milan S Geybels, Kristina M Jordahl, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findingsUrsula M Vogl, Tomasz M Beer, Ian D Davis, et al.
JCO Clinical Cancer Informatics|January 19, 2019
A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate CancerFatemeh Seyednasrollah, Devin C Koestler, Tao Wang, et al.
Journal of Medicinal Chemistry|September 2, 2005
Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinaseKim F McClure, Yuriy A Abramov, Ellen R Laird, et al.
European Urology Focus|October 9, 2020
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line ChemotherapyChristian Daniel Fankhauser, Ben Tran, Manuel Pedregal, et al.
The Lancet. Oncology|November 20, 2016
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial dataJustin Guinney, Tao Wang, Teemu D Laajala, et al.
Journal of the American Veterinary Medical Association|July 3, 2008
The Association of Shelter Veterinarians veterinary medical care guidelines for spay-neuter programsAndrea L Looney, Mark W Bohling, Philip A Bushby, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2002
Synthesis and biological activity of selective pipecolic acid-based TNF-alpha converting enzyme (TACE) inhibitorsMichael A Letavic, Matt Z Axt, John T Barberia, et al.
Cancer Immunology Research|March 29, 2024
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate CancerAtish D Choudhury, Lucia Kwak, Alexander Cheung, et al.
Pageof 77

Showing results (721-730 of 762) with videos related to

Sort By:
Pageof 77
The New Phytologist|July 1, 2021
An integrated framework of plant form and function: the belowground perspectiveAlexandra Weigelt, Liesje Mommer, Karl Andraczek, et al.
The Prostate|May 6, 2021
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancerVictoria Wang, Milan S Geybels, Kristina M Jordahl, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findingsUrsula M Vogl, Tomasz M Beer, Ian D Davis, et al.
JCO Clinical Cancer Informatics|January 19, 2019
A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate CancerFatemeh Seyednasrollah, Devin C Koestler, Tao Wang, et al.
Journal of Medicinal Chemistry|September 2, 2005
Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinaseKim F McClure, Yuriy A Abramov, Ellen R Laird, et al.
European Urology Focus|October 9, 2020
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line ChemotherapyChristian Daniel Fankhauser, Ben Tran, Manuel Pedregal, et al.
The Lancet. Oncology|November 20, 2016
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial dataJustin Guinney, Tao Wang, Teemu D Laajala, et al.
Journal of the American Veterinary Medical Association|July 3, 2008
The Association of Shelter Veterinarians veterinary medical care guidelines for spay-neuter programsAndrea L Looney, Mark W Bohling, Philip A Bushby, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2002
Synthesis and biological activity of selective pipecolic acid-based TNF-alpha converting enzyme (TACE) inhibitorsMichael A Letavic, Matt Z Axt, John T Barberia, et al.
Cancer Immunology Research|March 29, 2024
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate CancerAtish D Choudhury, Lucia Kwak, Alexander Cheung, et al.
Pageof 77